TY  - GEN
AU  - Kallage,V
AU  - Müller,J E
AU  - Zimmermann,M
AU  - Beck,J D
AU  - Ritter,J
AU  - Creutzig,U
TI  - [Prognosis, treatment completion, and complications in nonresponders in the study AML-BFM87]
SN  - 0300-8630
PY  - 1999///1022
KW  - Acute Disease
KW  - Adolescent
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Agents, Phytogenic
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bone Marrow Transplantation
KW  - Child
KW  - Cytarabine
KW  - Drug Administration Schedule
KW  - Drug Resistance, Neoplasm
KW  - Etoposide
KW  - Female
KW  - Humans
KW  - Infant, Newborn
KW  - Leukemia, Myeloid
KW  - drug therapy
KW  - Male
KW  - Remission Induction
KW  - Survival Analysis
KW  - Treatment Failure
N1  - Publication Type: Clinical Trial; English Abstract; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1055/s-2008-1043797
ER  -